The role of M1 and M2 macrophages in prostate cancer in relation to extracapsular tumor extension and biochemical recurrence after radical prostatectomy.
about
A Perspective of Immunotherapy for Prostate CancerThe inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approachImmune Infiltration and Prostate CancerFrom bench to bedside: immunotherapy for prostate cancerPrognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical reviewβ-Adrenergic Receptor Signaling in Prostate CancerInterferon-γ and celecoxib inhibit lung-tumor growth through modulating M2/M1 macrophage ratio in the tumor microenvironmentExposure of tumor-associated macrophages to apoptotic MCF-7 cells promotes breast cancer growth and metastasis.Inflammation and prostate cancer: friends or foe?Regulation of prostate cancer progression by the tumor microenvironment.Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions.Synergistic immunologic targets for the treatment of prostate cancer.Peripheral monocyte count: an independent diagnostic and prognostic biomarker for prostate cancer - a large Chinese cohort studyBeyond the Immune Suppression: The Immunotherapy in Prostate Cancer.Effect of Dietary Omega-3 Fatty Acids on Tumor-Associated Macrophages and Prostate Cancer Progression.Alternatively activated macrophages are associated with metastasis and poor prognosis in prostate adenocarcinoma.PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapy.The inflammatory microenvironment and microbiome in prostate cancer development.Prognostic role of tumour-associated macrophages and macrophage scavenger receptor 1 in prostate cancer: a systematic review and meta-analysis.Macrophage roles in the clearance of apoptotic cells and control of inflammation in the prostate gland after castration.Inflammatory Cytokine Signaling during Development of Pancreatic and Prostate Cancers.Immunotherapy for Prostate Cancer: Where We Are Headed.Long non-coding RNA cox-2 prevents immune evasion and metastasis of hepatocellular carcinoma by altering M1/M2 macrophage polarization.Multi-lectin Affinity Chromatography and Quantitative Proteomic Analysis Reveal Differential Glycoform Levels between Prostate Cancer and Benign Prostatic Hyperplasia Sera.Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer.Immune phenotypes of prostate cancer cells: Evidence of epithelial immune cell-like transition?Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy.Epigenetic control of macrophage polarization: implications for targeting tumor-associated macrophages.Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis.Genetics and biology of prostate cancerCirculating monocytes from prostate cancer patients promote invasion and motility of epithelial cells
P2860
Q26741277-15F551D4-3CBC-4038-91CB-C2AD85A33D3DQ26765937-C6AA6539-FA09-4F64-A23C-0B7CAD38EC3BQ26798412-AE5376B2-1FB3-4E80-9272-2889A21DFFCDQ26864390-F65F242A-CA19-479A-A646-9E74F0A95789Q28073742-89D2EAB5-B5E3-49CB-A099-5196B81B799FQ28084943-57D72B25-CC66-406D-97DF-36C2FBA6781EQ34273676-2F0B8B8A-BAC6-4AC5-85EA-E6AA2DB7941BQ35813735-8FED6B41-FDC9-490F-8393-357C8277749EQ38383521-76E47E3B-3A19-4388-98F9-03D770C7B11DQ38717262-265133AD-6A5C-463F-B160-9BAE48988C93Q38824706-8F01204B-8BE3-4289-BBD8-FD0799F97DDFQ38904873-E415412C-7348-4B72-AEC2-FA11F9755C9FQ41486852-F4FA2616-BB59-4238-846F-3E59F52BF1B7Q41573500-FAC8DE84-D18B-4BE7-80B2-414924872054Q41585891-8F52AE1B-B494-406C-8526-D6F58DC2D7BFQ42438837-B6B73FE9-2E71-4852-BF2F-6D7D0E9BB076Q42487948-586547D7-7956-4A34-870B-4A70485E5528Q46271291-9C47BC7C-ADA7-41FC-8A0B-606C75CB33DEQ47165172-BD9AD5DB-6496-40ED-9F09-F9310BA617B7Q47405998-7272AF41-7460-462F-995B-3596BAA98177Q48146142-E5A0A3D6-52BA-4D1D-BFA6-31412A188AF0Q48176349-A3F04409-EF93-4E8B-A8A0-1AB8B125AE45Q48316977-0BE5EDD4-E59D-4D83-9B55-1E7936465F15Q54949772-B4C98A5C-35B6-4E93-9435-3277B497B74AQ55023660-D8B46E89-48EA-4891-92CD-884813B8DC8BQ55079680-9AD81FE9-AD70-42D6-935E-A1DCC1D9F33CQ55156621-FB71CF17-240B-4A52-9E4E-60C05B5B6CECQ55266134-0D01A94F-A2EF-4CF8-987B-0279A497E0A9Q55364968-FBE6142D-E78C-40DD-8303-109485418031Q57106917-61841D92-79A4-4CF0-A67A-2E4A2A52825EQ58792097-C95DF628-1408-40E5-A2BA-327D1FEF272B
P2860
The role of M1 and M2 macrophages in prostate cancer in relation to extracapsular tumor extension and biochemical recurrence after radical prostatectomy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The role of M1 and M2 macropha ...... e after radical prostatectomy.
@en
The role of M1 and M2 macropha ...... e after radical prostatectomy.
@nl
type
label
The role of M1 and M2 macropha ...... e after radical prostatectomy.
@en
The role of M1 and M2 macropha ...... e after radical prostatectomy.
@nl
prefLabel
The role of M1 and M2 macropha ...... e after radical prostatectomy.
@en
The role of M1 and M2 macropha ...... e after radical prostatectomy.
@nl
P2093
P2860
P50
P356
P1476
The role of M1 and M2 macropha ...... e after radical prostatectomy.
@en
P2093
A Minervini
M R Raspollini
P Chiarugi
P2860
P304
P356
10.1155/2014/486798
P407
P577
2014-03-11T00:00:00Z